Monomeric CXCL121 peptide and methods of use thereof
Abstract:
The present invention provides a CXCL121 peptide engineered to resist peptide-induced dimerization by maintaining steric repulsion of the chemokine helix, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of cancer, inflammatory disorders, autoimmune disease, and HIV/AIDS.
Public/Granted literature
Information query
Patent Agency Ranking
0/0